| abstract |
An injection which contains as the active ingredient a pyrazolone derivative which typically is edaravon, a physiologically acceptable salt thereof, or a hydrate or solvate of either in an amount of 3 to 60 mg/mL. It is excellent in long-term stability, product storage, and suitability for use. |